Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Trajectory for the Non-Insulin Therapies For Diabetes Market by 2033?

The non-insulin therapies for diabetes market has shown strong growth, projected to rise from $18.71 billion in 2023 to $19.98 billion in 2024, at a CAGR of 6.8%. Contributing factors include increasing diabetes prevalence, greater awareness of diabetes management, rising healthcare expenditures, lifestyle changes leading to higher incidence rates, and government initiatives for diabetes care.

The non-insulin therapies for diabetes market is expected to reach $26.14 billion by 2028 at a CAGR of 6.9%. The growth is driven by rising diabetes prevalence, increasing awareness of diabetes management, and a growing preference for oral medications. Trends include advancements in drug delivery systems, the adoption of telemedicine, and developments in combination therapies.

Claim Your Free Sample of the Global Non-Insulin Therapies For Diabetes Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=16494&type=smp

What Factors Are Leading to Growth in the Non-Insulin Therapies For Diabetes Market?

The rising prevalence of diabetes is expected to boost the non-insulin diabetes therapies market. Diabetes is marked by high blood sugar levels due to insufficient insulin production or ineffective use of insulin. Factors contributing to this rise include sedentary lifestyles, unhealthy diets, genetic predispositions, and aging populations. Non-insulin therapies improve insulin sensitivity and glycemic control, addressing the condition effectively. In 2021, the International Diabetes Federation reported that approximately 537 million adults globally were living with diabetes, with projections of 643 million by 2030 and 783 million by 2045. Therefore, the increasing diabetes prevalence is propelling the non-insulin therapies market.

Which Segments Play a Key Role in Understanding the Non-Insulin Therapies For Diabetes Market?

1) By Drug Class: Biguanides, Sulfonylureas, Thiazolidinedione’s, Alpha-Glucosidase Inhibitors, Dipeptidyl peptidase-4 (DPP-4) Inhibitors, Glucagon-like peptide-1 (GLP-1) Analogs, Sodium-glucose co-transporter-2 (SGLT2) Inhibitors

2) By Route Of Administration: Oral, Intramuscular

3) By Distribution Channel: Retail Pharmacy, Hospital Pharmacy, Online Pharmacy

4) By Application: Monitoring, Diagnosis, Treatment, Other Applications

What Trends Are Emerging as Game-Changers in the Non-Insulin Therapies For Diabetes Market?

In the non-insulin therapies for diabetes market, companies are developing personalized diabetes management systems to improve patient outcomes. For instance, in November 2022, Eli Lilly and Company launched the Tempo personalized diabetes management platform, which helps adults with diabetes make informed treatment decisions.

Order Now for Fast Delivery of Your Non-Insulin Therapies For Diabetes Market Report!

https://www.thebusinessresearchcompany.com/report/non-insulin-therapies-for-diabetes-global-market-report

Which Regions Are Setting the Pace for Non-Insulin Therapies For Diabetes Market Growth?

North America was the largest region in the non-insulin therapies for diabetes market in 2023. The regions covered in the non-insulin therapies for diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Non-Insulin Therapies For Diabetes Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the non-insulin therapies for diabetes market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Non-Insulin Therapies For Diabetes Market Include

1. Non-Insulin Therapies For Diabetes Market Executive Summary

2. Non-Insulin Therapies For Diabetes Market Segments

3. Non-Insulin Therapies For Diabetes Market Size And Template Market Growth Rate

4. Key Non-Insulin Therapies For Diabetes Market Trends

5. Major Non-Insulin Therapies For Diabetes Market Drivers

……

25. Key Mergers And Acquisitions In The Non-Insulin Therapies For Diabetes Market

26. Top Non-Insulin Therapies For Diabetes Companies

27. Non-Insulin Therapies For Diabetes Market Opportunities And Strategies

28. Non-Insulin Therapies For Diabetes Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Insulin Patch Pumps Global Market Report 2024

https://www.thebusinessresearchcompany.com/sample_request?id=6486&type=smp

Insulin Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/insulin-biosimilars-global-market-report

Non-injectable Insulin Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/non-injectable-insulin-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: